Karyopharm Therapeutics (KPTI) Stock Price & Financial Analysis
Karyopharm Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Karyopharm Therapeutics
What is the current stock price for KPTI?
As of the latest trading session, KPTI stock trades at $9.02. The 52-week range is $3.65–$10.99, with a day range of $8.90–$9.73.
What is the P/E ratio for KPTI?
The P/E ratio (Price-to-Earnings) for KPTI is shown in the Key Statistics section. This valuation metric helps compare Karyopharm Therapeutics Inc. to industry peers.
Does KPTI pay dividends?
Karyopharm Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for KPTI?
Based on 4 analysts, the consensus for KPTI is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of KPTI?
Karyopharm Therapeutics's market capitalization is $222.9M, classifying it as a micro-cap company. Karyopharm Therapeutics operates in the Healthcare sector within the Biotechnology industry.